These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20967127)

  • 1. Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy.
    Laird AS; Van Hoecke A; De Muynck L; Timmers M; Van den Bosch L; Van Damme P; Robberecht W
    PLoS One; 2010 Oct; 5(10):e13368. PubMed ID: 20967127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic effects of progranulin in vivo in reversing motor neuron defects caused by over or under expression of TDP-43 or FUS.
    Chitramuthu BP; Kay DG; Bateman A; Bennett HP
    PLoS One; 2017; 12(3):e0174784. PubMed ID: 28358904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice.
    Beel S; Herdewyn S; Fazal R; De Decker M; Moisse M; Robberecht W; Van Den Bosch L; Van Damme P
    Mol Neurodegener; 2018 Oct; 13(1):55. PubMed ID: 30326935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats.
    Herdewyn S; De Muynck L; Van Den Bosch L; Robberecht W; Van Damme P
    Neurobiol Aging; 2013 Oct; 34(10):2302-3. PubMed ID: 23608112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.
    Ward ME; Taubes A; Chen R; Miller BL; Sephton CF; Gelfand JM; Minami S; Boscardin J; Martens LH; Seeley WW; Yu G; Herz J; Filiano AJ; Arrant AE; Roberson ED; Kraft TW; Farese RV; Green A; Gan L
    J Exp Med; 2014 Sep; 211(10):1937-45. PubMed ID: 25155018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
    Chen-Plotkin AS; Xiao J; Geser F; Martinez-Lage M; Grossman M; Unger T; Wood EM; Van Deerlin VM; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2010 Jan; 119(1):111-22. PubMed ID: 19649643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontotemporal dementia (FTD) and genetic mutations including progranulin gene].
    Arai T; Hasegawa M; Nishihara M; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H
    Rinsho Shinkeigaku; 2008 Nov; 48(11):990-3. PubMed ID: 19198141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amygdala TDP-43 Pathology in Frontotemporal Lobar Degeneration and Motor Neuron Disease.
    Takeda T; Seilhean D; Le Ber I; Millecamps S; Sazdovitch V; Kitagawa K; Uchihara T; Duyckaerts C
    J Neuropathol Exp Neurol; 2017 Sep; 76(9):800-812. PubMed ID: 28859337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43.
    Zhang YJ; Xu YF; Dickey CA; Buratti E; Baralle F; Bailey R; Pickering-Brown S; Dickson D; Petrucelli L
    J Neurosci; 2007 Sep; 27(39):10530-4. PubMed ID: 17898224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical degeneration in frontotemporal lobar degeneration with TDP-43 proteinopathy caused by progranulin gene mutation.
    Armstrong RA
    Int J Neurosci; 2014 Dec; 124(12):894-903. PubMed ID: 24494724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
    Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
    Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.
    Kabashi E; Lin L; Tradewell ML; Dion PA; Bercier V; Bourgouin P; Rochefort D; Bel Hadj S; Durham HD; Vande Velde C; Rouleau GA; Drapeau P
    Hum Mol Genet; 2010 Feb; 19(4):671-83. PubMed ID: 19959528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion.
    Shankaran SS; Capell A; Hruscha AT; Fellerer K; Neumann M; Schmid B; Haass C
    J Biol Chem; 2008 Jan; 283(3):1744-1753. PubMed ID: 17984093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.
    Armstrong RA; Cairns NJ
    Histol Histopathol; 2011 Feb; 26(2):185-90. PubMed ID: 21154232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
    Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
    Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-Species Differences in Regulation of the Progranulin-Sortilin Axis in TDP-43 Cell Models of Neurodegeneration.
    Gumina V; Onesto E; Colombrita C; Maraschi A; Silani V; Ratti A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
    Shan X; Vocadlo D; Krieger C
    Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.